Background illustration for clinical trials search

Paid Clinical Trials North Carolina

Discover 2,450 paid clinical trials in North Carolina. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Genetic Risk Factors Associated With Antiphospholipid Antibody Syndrome

for
Antiphospholipid Syndrome
Location: Durham NC
Sponsor: Duke University

Sex: All

Age: 0+

Code: NCT00482794

Recruiting

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

for
Non-alcoholic Fatty Liver Disease
Location: Quebec, New York NY, Norfolk VA, Morehead City NC,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 70+

Code: NCT07221227

Phase3, Recruiting

An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)

for
Progressive Metastatic Castrate Resistant Prostate Cancer
Location: Halifax, Boston MA, Durham NC, Cleveland OH, Atlanta GA,
Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18+

Code: NCT07206056

Phase1, Phase2, Recruiting

Pyloric Sphincter Abnormalities in Patients With Gastroparesis Symptoms

for
Gastroparesis, Idiopathic Gastric Motility Disorder,
Location: Boston MA, Philadelphia PA, Winston-Salem NC,
Sponsor: Johns Hopkins Bloomberg School of Public Health

Sex: All

Age: 18 - 70+

Code: NCT04661215

Recruiting

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

for
Non-muscle Invasive Bladder Cancer
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07206225

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

for
Metastatic Castration-Resistant Prostate Cancer
Location: New Haven CT, Myrtle Beach SC, Charlottesville VA,
Sponsor: Kyntra Bio

Sex: Male

Age: 18+

Code: NCT06842498

Phase2, Recruiting

CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis

for
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Location: Boston MA, New Haven CT, Manhasset NY, Rosedale NY,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 18+

Code: NCT07207811

Phase3, Recruiting

Mobile Intervention for Suicidal Thoughts

for
Suicide
Location: Durham NC
Sponsor: VA Office of Research and Development

Sex: All

Age: 18+

Code: NCT06593379

Recruiting

A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy

for
Duchene Muscular Dystrophy
Location: Boston MA, Worcester MA, New York NY,
Sponsor: ITF Therapeutics LLC

Sex: All

Age: 6+

Code: NCT07127978

Recruiting

A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee

for
Osteoarthritis
Location: Waltham MA, Quebec, Waterbury CT, Somerset NJ, Joliette,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07153471

Phase3, Recruiting

A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Durham NC, Kansas City MO, Seattle WA, San Francisco CA
Sponsor: VA Office of Research and Development

Sex: All

Age: 18 - 70+

Code: NCT06520098

Phase2, Recruiting

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

for
Chronic Obstructive Pulmonary Disease
Location: Boston MA, Flushing NY, East Orange NJ, Philadelphia PA,
Sponsor: Sanofi

Sex: All

Age: 40 - 70+

Code: NCT07190209

Phase3, Recruiting

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

for
Chronic Obstructive Pulmonary Disease
Location: New Bedford MA, Quebec, Victoriaville, Trois-Rivieres,
Sponsor: Sanofi

Sex: All

Age: 40 - 70+

Code: NCT07190222

Phase3, Recruiting

Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma

for
Advanced Or Metastatic Merkel Cell Carcinoma
Location: Boston MA, Hackensack NJ, Morristown NJ, Greenville NC,
Sponsor: TuHURA Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT06947928

Phase2, Phase3, Recruiting

Epidermal Sensors for Wireless and Enhanced Amputee Skin Tracking (E-SWEAT) Part 1

for
Transtibial Amputation
Location: Raleigh NC
Sponsor: North Carolina State University

Sex: All

Age: 18 - 70+

Code: NCT07216183

Phase1, Recruiting

Intent of Surgery for IPMN

for
Intraductal Papillary Mucinous Neoplasm
Location: Boston MA, New York NY, Baltimore MD, Durham NC,
Sponsor: NYU Langone Health

Sex: All

Age: 18+

Code: NCT07216521

Recruiting

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

for
Locally Advanced Cervical Adenocarcinoma,
Location: Bath ME, Portland ME, Scarborough ME, Sanford ME,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT07061977

Phase3, Recruiting

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

for
Cachexia, Metastatic Pancreatic Ductal Adenocarcinoma
Location: Chicoutimi, New York NY, Summit NJ, New Brunswick NJ,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT06989437

Phase2, Phase3, Recruiting

Safety of RSV Preventive Monoclonal Antibody

for
Fever, Adverse Event Following Immunisation
Location: New York NY, Durham NC, Atlanta GA, Cincinnati OH,
Sponsor: Duke University

Sex: All

Age: 0

Code: NCT07158814

Recruiting

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

for
Urothelial Cancer, Bladder Cancer
Location: Norfolk VA, Chapel Hill NC, Grand Rapids MI,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT07129993

Phase2, Phase3, Recruiting

Popular cities in North Carolina

High PointGreensboroCharlotteDurhamWilmingtonRaleigh